You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Clotrimazole And Betamethasone Dipropionate, and what generic alternatives are available?

Clotrimazole And Betamethasone Dipropionate is a drug marketed by Actavis Mid Atlantic, Fougera Pharms, Glenmark Speclt, and Taro. and is included in six NDAs.

The generic ingredient in CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
  • What are the global sales for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
  • What is Average Wholesale Price for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?
Summary for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
US Patents:0
Applicants:4
NDAs:6
Finished Product Suppliers / Packagers: 17
Raw Ingredient (Bulk) Api Vendors: 4
Clinical Trials: 1
What excipients (inactive ingredients) are in CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE?CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE excipients list
DailyMed Link:CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE at DailyMed
Drug patent expirations by year for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Recent Clinical Trials for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ache Laboratorios Farmaceuticos S.A.Phase 3

See all CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE clinical trials

Pharmacology for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

US Patents and Regulatory Information for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 076002-001 Aug 2, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 075673-001 May 29, 2001 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 075502-001 Jun 5, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.